University of Washington

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Washington sits in the top decile of US sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count).

1,048 total trials 156 currently recruiting 720 completed early-phase tilt top decile by trial count

University of Washington: 1,048 sponsored US clinical trials, 156 recruiting.

University of Washington sponsors 1,048 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 720 completed. 104 of these trials are in Phase 3-4 (later-stage) and 320 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 13 trials.

Top-decile sponsor footprint

University of Washington ranks in the top decile of sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 60/100

720 of 816 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,048 total, page 7 of 21

COMPLETED NA

Colonoscopy Outreach for Rural Communities Aim 2

NCT05453630
COMPLETED NA

Clinical Trial of a Supporter-Targeted Intervention to Improve Outcomes in Recent Sexual Assault Survivors

NCT05345405
COMPLETED NA

Testing Brief Personalized Feedback Integrating EMA Alcohol Cue Information

NCT05373706
COMPLETED NA

Virtual Reality Analgesia for Brief Thermal Pain

NCT05130307
TERMINATED Phase 1

Lefamulin for M. Genitalium Treatment Failures

NCT05111002
TERMINATED Phase 1

Bomedemstat and Maintenance Immunotherapy for Treatment of Newly Diagnosed Extensive Stage Small Cell Lung Cancer

NCT05191797
COMPLETED NA

Coping Skills for Alcohol Use

NCT05356533
COMPLETED Phase 2

Mosunetuzumab With or Without Polatuzumab Vedotin and Obinutuzumab for the Treatment of Untreated Indolent B-Cell Non-Hodgkin Lymphoma

NCT05169658
COMPLETED Phase 3

Frontline Clinician Psilocybin Study

NCT05163496
COMPLETED NA

Use of Partial Body Weight Support Play Environment to Encourage Mobility and Exploration in Infants With Down Syndrome

NCT05307523
COMPLETED

Comparison Neuromuscular Blockade Monitors

NCT05006807
COMPLETED Phase 4

Sugammadex Titration in Cardiac Surgery Patients

NCT05246397
COMPLETED NA

Preventing Medication-Related Problems in Care Transitions to Skilled Nursing Facilities

NCT05241951
COMPLETED NA

Reopening Schools Safely and Educating Youth Research Study (ROSSEY)

NCT04859699
COMPLETED NA

Peer Mentor Texting

NCT07380061
COMPLETED NA

Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE Trial

NCT04667481
COMPLETED NA

Mobile Health Intervention to Support Healthful Diet

NCT05236712
COMPLETED NA

Brief Telehealth Cognitive Rehabilitation Following Mild TBI

NCT05315453
TERMINATED Phase 2

ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy

NCT04372927
COMPLETED NA

Lung Transplant READY Pilot Study

NCT05135156
COMPLETED NA

eLearning for Suicide Prevention

NCT05178121
COMPLETED NA

Enhancing Engagement With Digital Mental Health Care

NCT04507360
COMPLETED NA

Online Field Test of an Appendicitis Decision Support Tool

NCT05219786
COMPLETED NA

Improving Asthma Care Together (IMPACT): A Shared Management Pilot Study

NCT04908384
COMPLETED Phase 4

Effect of Post-Operative Anesthetics on Post-Operative Pain in Patients Receiving Endodontic Treatment

NCT05338671
COMPLETED NA

Efficacy of Plaque Removal of a Novel Brushing Device

NCT05038293
COMPLETED NA

Return to Learn Implementation Bundle for Schools (RISE) After Youth Concussion

NCT04635475
COMPLETED NA

Research Evaluating Sleep & Trends for Universal Prevention

NCT04783519
COMPLETED NA

Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)

NCT04283994
COMPLETED

Appendicitis Choice of Treatment Study

NCT04968782
COMPLETED

Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol

NCT05384899
COMPLETED Phase 2

Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer

NCT04505553
COMPLETED

MENstrual Symptom Tracking to Understand and Assess (Women) Living With Cystic Fibrosis

NCT04620096
COMPLETED NA

Assessing the Effectiveness of Reciprocal Imitation Teaching in Part C Early Intervention Settings (Sprout Study)

NCT05425277
COMPLETED NA

IPF mHealth Exercise Study

NCT04838275
COMPLETED NA

Use of Audio Recordings of Self-Hypnosis and Meditation for Fatigue Management in Multiple Sclerosis

NCT04688710
COMPLETED Phase 4

Ketamine Versus Fentanyl for Surgical Abortions

NCT04871425
TERMINATED Phase 2

Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer

NCT04442581
COMPLETED NA

Early Powered Mobility for Toddlers With Cerebral Palsy Using the Permobil® Explorer Mini and a Modified Ride-On Car

NCT04684576
TERMINATED Phase 2

Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load

NCT04336943
COMPLETED NA

A Study on the Use of Real -Time Continuous Glucose Monitoring (RT-CGM) in Gestational Diabetes

NCT04803357
COMPLETED NA

Stay Connected: Testing an Intervention to Combat Coronavirus-related Social Isolation Among Older Adults

NCT04966910
COMPLETED NA

IUD Self-Removal: Evaluating an Online Guide for Self-removal in Clinical and Non-clinical Settings

NCT06042556
COMPLETED NA

Reducing CNS-Active Medications to Prevent Falls and Injuries in Older Adults

NCT05689554
TERMINATED

Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT04852822
COMPLETED Early Phase 1

Naloxone Auto-injection in Healthy Volunteers

NCT05099614
COMPLETED NA

Assisted Partner Services and HIVST in Western Kenya

NCT04774835
COMPLETED NA

The Use of Mentoring to Promote Well-being for Female SMART Members

NCT04247880
COMPLETED NA

Tools for Health and Resilience Implemented After Violence Exposure (Project THRIVE)

NCT03703258
COMPLETED

Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study)

NCT05074719
← Previous Page 7 of 21 Next →

Phase Distribution

PhaseTrial count
Phase 1 127
Phase 2 193
Phase 3 39
Phase 4 65

Therapeutic Areas

Depression 13
Chronic Pain 9
Dementia 8
Multiple Sclerosis 8
Post Traumatic Stress Disorder 7
Stage IV Breast Cancer 6
Pain 6
Anatomic Stage IV Breast Cancer AJCC v8 6
Anatomic Stage III Breast Cancer AJCC v8 6
Spinal Cord Injuries 6

What is open in the University of Washington pipeline

156 recruiting of 1,048 indexed (15% open); 720 completed (69%).

Phase mix: 104 late (III/IV) vs 320 early (I/II) (early-phase heavy).

Top condition: Depression (13 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Washington: open-pipeline peers nationwide

Peers matched on 1,048 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 6%8%10%12%14%16% Total trials Recruiting share University of WashingtonUniversity of Wisconsin, MadisonBristol-Myers SquibbUniversity of FloridaUniversity of North Carolina, Chapel HillDompé Farmaceutici S.p.AVanderbilt-Ingram Cancer CenterArizona State UniversityGeorgetown University
University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,048 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Washington page

1,048 registered trials is a research-attention snapshot, not an endorsement of University of Washington or any single study.

  • 156 of University of Washington's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Washington studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Washington pipeline card: 1,048 registered trials from official public datasets.Report a data error.